Dupixent 200 MG/1.14 ML syring 1.14ML
Ended Awarded Last action
- Contract number
- SPE2DR26FMH5J
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,963
Award facts
- Contract value 100% obligated
- $11,962.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,962.52 to AmerisourceBergen Drug Corp for the supply of Dupixent (dupilumab) 200 mg/1.14 mL syringes on December 3, 2025, with an ultimate completion date of December 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dupixent is a biologic immunosuppressant medication used to treat eczema, asthma, and chronic rhinosinusitis, representing a critical specialty pharmaceutical product for federal military and healthcare system requirements.
This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. This comprehensive global pharmaceutical support vehicle enables the contractor to supply a wide range of specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support Defense Health Agency operations and other federal healthcare systems worldwide. As a major pharmaceutical distributor and established federal vendor, AmerisourceBergen regularly fulfills medical procurement requirements for military and veteran healthcare systems through competitively awarded contracts demonstrating its capability to meet federal supply standards across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FMH5J?
SPE2DR26FMH5J was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 3, 2025.
How much is contract SPE2DR26FMH5J worth?
The government has obligated $11,963 on SPE2DR26FMH5J.
Is contract SPE2DR26FMH5J an order under another contract?
Yes. SPE2DR26FMH5J is a delivery order under SPE2DR25D1200, an indefinite delivery contract.
Was contract SPE2DR26FMH5J competed?
The extent of competition for SPE2DR26FMH5J was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award